Načítá se...
Current status and future perspectives of liquid biopsy in non-small cell lung cancer
With advances in target therapy, molecular analysis of tumors is routinely required for treatment decisions in patients with advanced non-small cell lung cancer (NSCLC). Liquid biopsy refers to the sampling and analysis of circulating cell-free tumor DNA (ctDNA) in various body fluids, primarily blo...
Uloženo v:
| Vydáno v: | J Pathol Transl Med |
|---|---|
| Hlavní autoři: | , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
The Korean Society of Pathologists and the Korean Society for Cytopathology
2020
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7253954/ https://ncbi.nlm.nih.gov/pubmed/32460474 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4132/jptm.2020.02.27 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|